Inhibitor Therapeutics Market Cap

Inhibitor Therapeutics has a market cap or net worth of $14.76 million as of April 24, 2024. Its market cap has increased by 38.57% in one year.

Market Cap

14.76M

Enterprise Value

5.92M

1-Year Change

38.57%

Ranking

n/a

Market Cap Chart

Since April 25, 2019, Inhibitor Therapeutics's market cap has decreased from $19.63M to $14.76M, a decrease of -24.82%. That is a compound annual growth rate of -5.54%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2024	14.76M	50.53%
Apr 23, 2024	9.81M	-16.79%
Apr 17, 2024	11.78M	-6.80%
Apr 16, 2024	12.64M	-5.16%
Apr 10, 2024	13.33M	36.93%
Apr 9, 2024	9.74M	-17.13%
Apr 1, 2024	11.75M	-2.43%
Mar 28, 2024	12.04M	-
Mar 25, 2024	12.04M	2.08%
Mar 22, 2024	11.80M	-2.04%
Mar 20, 2024	12.04M	11.11%
Mar 19, 2024	10.84M	-10.00%
Mar 18, 2024	12.04M	-9.09%
Mar 15, 2024	13.24M	-3.75%
Mar 13, 2024	13.76M	8.84%
Mar 7, 2024	12.64M	-4.55%
Mar 6, 2024	13.24M	10.00%
Mar 1, 2024	12.04M	-12.50%
Feb 29, 2024	13.76M	-
Feb 28, 2024	13.76M	18.52%
Feb 27, 2024	11.61M	-15.63%
Feb 26, 2024	13.76M	-
Feb 23, 2024	13.76M	18.03%
Feb 22, 2024	11.66M	-15.28%
Feb 21, 2024	13.76M	-

View and export this data all the way back to 2019. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly	695.32B
Novo Nordisk	564.00B
UnitedHealth Group	452.88B
Johnson & Johnson	359.35B
Merck & Co.	321.49B
AbbVie	297.27B
AstraZeneca	217.39B
Thermo Fisher	209.32B

Market Cap Rankings